Clinical Trial

ATG Plus PTCy vs ATG for CGVHD Prophylaxis

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Randomized Pilot Trial to test the feasibility of comparing anti-thymocyte globulin plus post transplant cyclophosphamide with anti-thymocyte globulin alone to prevent chronic graft versus host disease.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-12-17; most recent amendment 2025-05-07.
Status change: Recruiting → Active, Not Recruiting 2025-05-07
Status change: Not Yet Recruiting → Recruiting 2021-03-03
Trial Details
NCT Number NCT04202835
Lead Sponsor McMaster University
Collaborators: Cell Therapy Transplant Canada, Sanofi, Ozmosis Research Inc.
Conditions Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease
Enrollment 80 participants
Start Date 2020-10-14
Primary Completion 2024-05-18 (estimated)
Study Completion 2026-02-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-11